UCLA Health System
It begins with U
Research and Education: David Geffen School of Medicine at UCLAPatient Care: UCLA Health System
Increase (+) Default Decrease (-) Font Size
About Us
Physician Directory
Medical Services
Quality & Service
Publications
Health Resources
Community Calendar
For Patients & Visitors
For Healthcare Professionals
For International Patients
Newsroom
For Journalists
For Staff
Watch our Webcasts


Tamara Horwich, MD

Email this page  Print  Bookmark
Tamara Beth Horwich, MD
Specialty
Cardiovascular Disease, Internal Medicine
Gender Language Spoken
Female English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
State License Number
A73443
Contact
(310) 825-8816
Fax Number
(310) 206-9111
Email Address
thorwich@mednet.ucla.edu
PRACTICE LOCATION

Peter Morton Medical Building
200 UCLA Medical Plaza, Suite 247
Los Angeles, CA 90095

MEDICAL BOARD CERTIFICATION
Cardiovascular Disease, American Board of Internal Medicine, 2006
Internal Medicine, American Board of Internal Medicine, 2002
EDUCATION
Fellowship
Cardiology, UCLA School of Medicine, 2002 - 2006
Residency
Internal Medicine, UCLA School of Medicine, 2000 - 2002
Internship
Internal Medicine, UCLA School of Medicine, 1999 - 2000
Medical Degree
MD, Columbia University College of Physicians,Surgeons, 1999
CLINICAL INTEREST
Cardiomyopathy
AFFILIATION
Department Affiliation
Physician, Cardiology, Heart Transplantation, Adult Cardiac Stress Testing and Echocardiographic Imaging Laboratory, Ahmanson-UCLA Cardiomyopathy Center, Interventional Cardiology
MORE INFORMATION
Research Interest

Heart Failure

Publications

1. Horwich T, Kalantar-Zadeh K, MacLellan WR, Fonarow GC. Albumin Levels Predict Survival in Patients with Systolic Heart Failure. American Heart Journal. In press.
2. Afsarmanesh N, Horwich TB. Fonarow GC. Total cholesterol levels and mortality risk in nonischemic systolic heart failure. Am Heart J 2006; 152: 1077-83.
3. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 2006; 97: 1759-64.
4. Eshaghian S, Horwich TB, Fonarow GC. An Unexpected Inverse Relationship Between HbA1c Levels and Mortality in Patients with Diabetes and Advanced Systolic Heart Failure. Am Heart J 2006: 151: 91.e1 – 91.e6.
5. Horwich TB, Hamilton MA, Fonarow GC. B-type Natriuretic Peptide Levels in Obese Patients with Advanced Heart Failure. J Am Coll Cardiol 2006; 47: 85-90.
6. Ralli S, Horwich TB, Fonarow GC. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels, and mortality in advanced heart failure. Am Heart J 2005; 150: 1220-7.
7. Smooke S, Horwich TB, Fonarow GC. Insulin treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. Am Heart J 2005;149:168-74.
8. Horwich T, Foster E, De Marco T, Tseng Z, Saxon L. Effects of Resynchronization Therapy on Cardiac Function in Pacemaker Patients 'Upgraded' to Biventricular Devices. J Cardiovasc Electrophysiol 2004; 15: 1284-9.
9. Tiersten A, Wo J, Jacobsen C, Weitzman A, Horwich T, Hesdorffer C, Savage D, and Troxel A. Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer. Breast 2004; 13: 341-6.
10. Horwich TB, MacLellan WR, Fonarow GC. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol 2004;43:642-648.
11. Horwich TB, Lee SJ, Saxon LA. QRS prolongation predicts risk of inducible monomorphic ventricular tachycardia in patients referred for electrophysiologic studies. Am J Cardiol 2003: 92;804-9.
12. Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac Troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality in advanced heart failure. Circulation 2003;108:833-8.
13. Horwich TB, Hamilton MA, MacLellan WR, Fonarow GC. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 2002;8:216-224.
14. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is Associated with Worse Symptoms, Greater Impairment in Functional Capacity, and a Significant Increase in Mortality in Patients with Advanced Heart Failure. J Am Coll Cardiol 2002;39:1780-6.
15. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with advanced heart failure. J Am Coll Cardiol 2001; 38:789-95.

Additional publications can be found in the PubMed.gov site. 

Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
 
Dr. Tamara Beth Horwich,  click here to update your profile.









Carepages - create a free web page with ease to communicate with family and friends.


Proud sponsor of the UCLA Athletics